ONTAK Side Effects

6976946-7 | Capillary Leak Syndrome, Cardiac Arrest
on Sep 02, 2010 Male patient from UNITED STATES , 66 years of age, was diagnosed with mycosis fungoides and was treated with Ontak (View Usage). Patient experienced the following unwanted or unexpected effects: capillary leak syndrome, cardiac arrest (What is cardiac arrest?). Ontak dosage: .

6958197-5 | Capillary Leak Syndrome
Patient was taking Ontak (View Usage). Patient had the following side effects: capillary leak syndrome on Aug 24, 2010 from Additional patient health information: Male patient , 31 years of age, . Ontak dosage: . Patient was hospitalized.

6933358-X |
Adverse event was reported on Aug 06, 2010 by a Male patient taking Ontak (View Usage) (Dosage: ) was diagnosed with hepatosplenic t-cell lymphoma and. Location: UNITED STATES , 22 years of age, . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), ONCOVIN (View Oncovin Review and Oncovin Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ).

6916608-5 | Capillary Leak Syndrome, Cardiac Valve Disease, Oedema
on Aug 03, 2010 Male patient from UNITED STATES , weighting 218.3 lb, was treated with Ontak (View Usage). Patient experienced the following unwanted or unexpected effects: capillary leak syndrome, cardiac valve disease, oedema. Ontak dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.


6914703-8 | Atrial Fibrillation, Capillary Leak Syndrome, Cardiac Valve Rupture, Hepatic Enzyme Increased
on Aug 04, 2010 Male patient from UNITED STATES , weighting 218.3 lb, was treated with Ontak (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), capillary leak syndrome, cardiac valve rupture, hepatic enzyme increased. Ontak dosage: 8875 Mg. During the same period patient was treated with RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) (800 Mg) (View Rituximab (moab C2b8 Anti Cd20, Chimeric) Review and Rituximab (moab C2b8 Anti Cd20, Chimeric) Label ). Patient was hospitalized.

6811837-3 | Hypoxia, Pulmonary Oedema, Pyrexia
Patient was taking Ontak (View Usage). After Ontak was administered, patient had the following side effects: hypoxia, pulmonary oedema, pyrexia on Jun 23, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 178.6 lb, . Ontak dosage: . During the same period patient was treated with MELANOMA SPECIFIC T CELLS (18.6 X 10^9) (View Melanoma-specific T Cells Review and Melanoma-specific T Cells Label ), PROLEUKIN (View Proleukin Review and Proleukin Label ). Patient was hospitalized.

6795239-4 | Cardiac Tamponade, Pericardial Effusion, Pleural Effusion, Pulmonary Oedema
Adverse event was reported on Jun 22, 2010 by a Female patient taking Ontak (View Usage) (Dosage: ) was diagnosed with t-cell lymphoma and. Location: UNITED STATES , weighting 132.3 lb, Patient experienced the following unwanted or unexpected effects: cardiac tamponade, pericardial effusion, pleural effusion, pulmonary oedema. During the same period patient was treated with ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), DEXTROSE 5% (View Dextrose 5% Review and Dextrose 5% Label ), DOCUSATE (View Docusate Review and Docusate Label ), ENTECAVIR (View Entecavir Review and Entecavir Label ), FILGRASTIM (View Filgrastim Review and Filgrastim Label ), HEPARIN (View Heparin Review and Heparin Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized.

6728002-0 | Acidosis, Alanine Aminotransferase Increased, Anaemia, Blood Bilirubin Increased, Blood Creatinine Increased, Bronchitis, Disease Progression, Fatigue, Febrile Neutropenia
on May 12, 2010 Male patient from UNITED STATES , weighting 244.7 lb, was diagnosed with prophylaxis and was treated with Ontak (View Usage). Patient had the following side effects: acidosis, alanine aminotransferase increased, anaemia, blood bilirubin increased, blood creatinine increased, bronchitis (What is bronchitis?), disease progression, fatigue, febrile neutropenia. Ontak dosage: . During the same period patient was treated with DAPSONE (View Dapsone Review and Dapsone Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LORTAB (View Lortab Review and Lortab Label ), ATIVAN (View Ativan Review and Ativan Label ). Patient was hospitalized.

6688964-7 | Alanine Aminotransferase, Anaemia, Blood Bilirubin Increased, Blood Creatinine Increased, Bronchitis, Fatigue, Febrile Neutropenia, Pyrexia, Renal Failure Acute
on Apr 10, 2010 Male patient from UNITED STATES , weighting 244.7 lb, was diagnosed with prophylaxis and was treated with Ontak (View Usage). After Ontak was administered, patient had the following side effects: alanine aminotransferase, anaemia, blood bilirubin increased, blood creatinine increased, bronchitis (What is bronchitis?), fatigue, febrile neutropenia, pyrexia, renal failure acute. Ontak dosage: . During the same period patient was treated with DAPSONE (View Dapsone Review and Dapsone Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LORTAB (View Lortab Review and Lortab Label ), ATIVAN (View Ativan Review and Ativan Label ). Patient was hospitalized.

6663921-5 | Arrhythmia, Blood Pressure Increased, Tachycardia
Patient was taking Ontak (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?), blood pressure increased, tachycardia on Mar 25, 2010 from UNITED STATES Additional patient health information: Female patient , 81 years of age, weighting 141.1 lb, was diagnosed with t-cell lymphoma, stress ulcer and. Ontak dosage: . During the same period patient was treated with ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), HYDROXIZINE (View Hydroxizine Review and Hydroxizine Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), VALSARTAN (View Valsartan Review and Valsartan Label ). Patient was hospitalized.

6657017-6 | Abdominal Pain, Asthenia, Dyspnoea, Malignant Neoplasm Progression, Metastases To Liver, Metastases To Lymph Nodes, Nausea, Pleural Effusion, Respiratory Failure
Adverse event was reported on Mar 29, 2010 by a Female patient taking Ontak (View Usage) (Dosage: 12mcg/m2 = 770mcg Total) was diagnosed with ovarian cancer and. Location: UNITED STATES , 50 years of age, weighting 136.0 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), asthenia, dyspnoea, malignant neoplasm progression, metastases to liver, metastases to lymph nodes, nausea (What is nausea?), pleural effusion, respiratory failure. Patient was hospitalized.

6635718-3 | Arrhythmia, Blood Pressure Increased, Tachycardia, Unevaluable Event
on Mar 12, 2010 Female patient from UNITED STATES , 81 years of age, weighting 141.1 lb, was diagnosed with t-cell lymphoma and was treated with Ontak (View Usage). After Ontak was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), blood pressure increased, tachycardia, unevaluable event. Ontak dosage: 18 Mcg/kg Once Iv Drip. Patient was hospitalized.

6634715-1 | Colitis
on Mar 05, 2010 Male patient from UNITED STATES , 51 years of age, weighting 205.0 lb, was treated with Ontak (View Usage). Patient experienced the following unwanted or unexpected effects: colitis. Ontak dosage: . During the same period patient was treated with TARGRETIN (View Targretin Review and Targretin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CRESTOR (View Crestor Review and Crestor Label ), NEXIUM (View Nexium Review and Nexium Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), AMBIEN (View Ambien Review and Ambien Label ), HYDROXYZINE (View Hydroxyzine Review and Hydroxyzine Label ). Patient was hospitalized.

6608610-8 | Enterocolitis Haemorrhagic
Patient was taking Ontak (View Usage). Patient had the following side effects: enterocolitis haemorrhagic on Feb 17, 2010 from UNITED STATES Additional patient health information: Male patient , 50 years of age, . Ontak dosage: 9mcg/kg. Patient was hospitalized.

6585457-2 | Asthenia, Capillary Leak Syndrome, Confusional State, Diarrhoea, Hypotension, Infusion Related Reaction, Pyrexia, Tachycardia, Vomiting
Adverse event was reported on Feb 16, 2010 by a Female patient taking Ontak (View Usage) (Dosage: 1000 Mg) . Location: UNITED STATES , weighting 126.1 lb, After Ontak was administered, patient had the following side effects: asthenia, capillary leak syndrome, confusional state, diarrhoea, hypotension, infusion related reaction, pyrexia, tachycardia, vomiting. During the same period patient was treated with RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) (600 Mg) (View Rituximab (moab C2b8 Anti Cd20, Chimeric) Review and Rituximab (moab C2b8 Anti Cd20, Chimeric) Label ). Patient was hospitalized.

6577534-7 | Asthenia, Cough, Dyspnoea, Haematuria, Hypoxia, Muscle Spasms, Oxygen Saturation Decreased, Pneumonitis Chemical, Pruritus
on Feb 02, 2010 Male patient from UNITED STATES , weighting 160.9 lb, was treated with Ontak (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, cough, dyspnoea, haematuria, hypoxia, muscle spasms, oxygen saturation decreased, pneumonitis chemical, pruritus. Ontak dosage: . During the same period patient was treated with TARGRETIN (View Targretin Review and Targretin Label ). Patient was hospitalized.

6526670-X | Oedema, Pain
on Dec 31, 2009 Male patient from UNITED STATES , weighting 180.8 lb, was diagnosed with lymphoma (What is lymphoma?) and was treated with Ontak (View Usage). Patient had the following side effects: oedema, pain (What is pain?). Ontak dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBIENE (View Doxorubiene Review and Doxorubiene Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), NEULASTA (View Neulasta Review and Neulasta Label ). Patient was hospitalized.

6509458-5 | Nausea, Neutropenia, Pyrexia
Patient was taking Ontak (View Usage). After Ontak was administered, patient had the following side effects: nausea (What is nausea?), neutropenia, pyrexia on Dec 10, 2009 from UNITED STATES Additional patient health information: Female patient , 64 years of age, . Ontak dosage: . Patient was hospitalized.

6493157-2 | Lymphopenia
Adverse event was reported on Dec 09, 2009 by a Female patient taking Ontak (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 134.5 lb, Patient experienced the following unwanted or unexpected effects: lymphopenia. During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN (View Doxorubicin Review and Doxorubicin Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ). Patient was hospitalized.

6490188-3 | Oedema, Pain
on Dec 09, 2009 Male patient from UNITED STATES , weighting 180.8 lb, was diagnosed with lymphoma (What is lymphoma?) and was treated with Ontak (View Usage). Patient had the following side effects: oedema, pain (What is pain?). Ontak dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBIENE (View Doxorubiene Review and Doxorubiene Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), NEULASTA (View Neulasta Review and Neulasta Label ). Patient was hospitalized.

6454335-1 | Infection
on Nov 19, 2009 Female patient from UNITED STATES , weighting 134.5 lb, was treated with Ontak (View Usage). After Ontak was administered, patient had the following side effects: infection (What is infection?). Ontak dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), NEULASTA (View Neulasta Review and Neulasta Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), VALACYCLOVIR HYDROCHLORIDE (View Valacyclovir Hydrochloride Review and Valacyclovir Hydrochloride Label ). Patient was hospitalized.

6453794-8 | Cardio-respiratory Arrest, Pain, Tachycardia
Patient was taking Ontak (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, pain (What is pain?), tachycardia on Nov 19, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 280.0 lb, . Ontak dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), NEULASTA (View Neulasta Review and Neulasta Label ), NORGESTIMATE (View Norgestimate Review and Norgestimate Label ), ETINOL (View Etinol Review and Etinol Label ), PRILOSEC (View Prilosec Review and Prilosec Label ). Patient was hospitalized.

6450590-2 | Oedema, Pain
Adverse event was reported on Nov 19, 2009 by a Male patient taking Ontak (View Usage) (Dosage: ) was diagnosed with lymphoma (What is lymphoma?) and. Location: UNITED STATES , weighting 180.8 lb, Patient had the following side effects: oedema, pain (What is pain?). During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBIENE (View Doxorubiene Review and Doxorubiene Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), NEULASTA (View Neulasta Review and Neulasta Label ). Patient was hospitalized.

6449962-1 | Capillary Leak Syndrome, Cardiac Valve Disease, Oedema
on Nov 13, 2009 Male patient from UNITED STATES , weighting 218.3 lb, was treated with Ontak (View Usage). After Ontak was administered, patient had the following side effects: capillary leak syndrome, cardiac valve disease, oedema. Ontak dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

6444990-4 | Abdominal Distension, Atrial Fibrillation, Capillary Leak Syndrome, Dyspnoea Exertional, Hepatic Enzyme Increased, Mitral Valve Disease, Palpitations, Weight Increased
on Nov 16, 2009 Male patient from UNITED STATES , weighting 218.3 lb, was treated with Ontak (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, atrial fibrillation (What is atrial fibrillation?), capillary leak syndrome, dyspnoea exertional, hepatic enzyme increased, mitral valve disease, palpitations, weight increased. Ontak dosage: 8875 Mg. During the same period patient was treated with RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) (800 Mg) (View Rituximab (moab C2b8 Anti Cd20, Chimeric) Review and Rituximab (moab C2b8 Anti Cd20, Chimeric) Label ). Patient was hospitalized.

6413616-8 | Pneumonitis
Patient was taking Ontak (View Usage). Patient had the following side effects: pneumonitis on Aug 28, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 227.1 lb, . Ontak dosage: . During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

6410690-X | Alanine Aminotransferase Abnormal, Aspartate Aminotransferase Abnormal, Blood Albumin Abnormal, Malaise, Oedema, Pain, Thrombocytopenia, Weight Increased
Adverse event was reported on Oct 20, 2009 by a Male patient taking Ontak (View Usage) (Dosage: 1395 Mcg) . Location: UNITED STATES , weighting 181.4 lb, After Ontak was administered, patient had the following side effects: alanine aminotransferase abnormal, aspartate aminotransferase abnormal, blood albumin abnormal, malaise, oedema, pain (What is pain?), thrombocytopenia, weight increased. During the same period patient was treated with RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) (708 Mg) (View Rituximab (moab C2b8 Anti Cd20, Chimeric) Review and Rituximab (moab C2b8 Anti Cd20, Chimeric) Label ), LASIX (View Lasix Review and Lasix Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6379492-7 | Alanine Aminotransferase Abnormal, Aspartate Aminotransferase Abnormal, Blood Albumin Abnormal, Malaise, Oedema, Pain, Thrombocytopenia, Weight Increased
on Sep 23, 2009 Male patient from UNITED STATES , weighting 181.4 lb, was treated with Ontak (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase abnormal, aspartate aminotransferase abnormal, blood albumin abnormal, malaise, oedema, pain (What is pain?), thrombocytopenia, weight increased. Ontak dosage: 1395 Mcg. During the same period patient was treated with RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) (708 Mg) (View Rituximab (moab C2b8 Anti Cd20, Chimeric) Review and Rituximab (moab C2b8 Anti Cd20, Chimeric) Label ), LASIX (View Lasix Review and Lasix Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6361458-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Albumin Decreased, Blood Creatine Phosphokinase Abnormal, Blood Potassium Decreased, Capillary Leak Syndrome, Fatigue, Muscular Weakness, Myalgia
on Sep 08, 2009 Female patient from UNITED STATES , weighting 299.8 lb, was diagnosed with lymphoma (What is lymphoma?) and was treated with Ontak (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood creatine phosphokinase abnormal, blood potassium decreased, capillary leak syndrome, fatigue, muscular weakness, myalgia. Ontak dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

6355859-8 | Asthenia, Blood Albumin Decreased, Myalgia, Myositis, Pain
Patient was taking Ontak (View Usage). After Ontak was administered, patient had the following side effects: asthenia, blood albumin decreased, myalgia, myositis (What is myositis?), pain (What is pain?) on Sep 10, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 301.6 lb, . Ontak dosage: 9600 Mcg. During the same period patient was treated with RITUXIMAB (MOAB C2B8 ANTI CD2O, CHIMERIC) (1936 Mcg) (View Rituximab (moab C2b8 Anti Cd2o, Chimeric) Review and Rituximab (moab C2b8 Anti Cd2o, Chimeric) Label ). Patient was hospitalized.

6342703-8 | Pneumonitis
Adverse event was reported on Aug 28, 2009 by a Male patient taking Ontak (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 227.1 lb, Patient experienced the following unwanted or unexpected effects: pneumonitis. During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

6329184-5 | Alanine Aminotransferase Abnormal, Aspartate Aminotransferase Abnormal, Blood Albumin Abnormal, Oedema, Pain, Thrombocytopenia, Weight Increased
on Aug 25, 2009 Male patient from UNITED STATES , weighting 181.4 lb, was treated with Ontak (View Usage). Patient had the following side effects: alanine aminotransferase abnormal, aspartate aminotransferase abnormal, blood albumin abnormal, oedema, pain (What is pain?), thrombocytopenia, weight increased. Ontak dosage: 1395 Mcg. During the same period patient was treated with RITUXIMAB (708 Mg) (View Rituximab Review and Rituximab Label ), LASIX (View Lasix Review and Lasix Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6312111-4 | Cardio-respiratory Arrest, Unresponsive To Stimuli
on Aug 13, 2009 Female patient from UNITED STATES , 53 years of age, weighting 144.4 lb, was diagnosed with ovarian cancer metastatic and was treated with Ontak (View Usage). After Ontak was administered, patient had the following side effects: cardio-respiratory arrest, unresponsive to stimuli. Ontak dosage: 12 Mcg/kg Iv Q 28 Days. During the same period patient was treated with ANTACID OTC (View Antacid Otc Review and Antacid Otc Label ), COMPAZINE (View Compazine Review and Compazine Label ), NAPROXEN (View Naproxen Review and Naproxen Label ).

6312103-5 | Upper Gastrointestinal Haemorrhage
Patient was taking Ontak (View Usage). Patient experienced the following unwanted or unexpected effects: upper gastrointestinal haemorrhage on Aug 13, 2009 from UNITED STATES Additional patient health information: Female patient , 68 years of age, weighting 141.8 lb, was diagnosed with ovarian cancer metastatic and. Ontak dosage: 12 Mcg/kg Iv Q 28 Days. During the same period patient was treated with ZOFRAN (View Zofran Review and Zofran Label ), MORPHINE SULFATE (View Morphine Sulfate Review and Morphine Sulfate Label ), ATIVAN (View Ativan Review and Ativan Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), PROTONIX (View Protonix Review and Protonix Label ), REGLAN (View Reglan Review and Reglan Label ).

6288476-9 | Capillary Leak Syndrome, Cytokine Release Syndrome, Dehydration, Enteritis, Muscular Weakness, Small Intestinal Obstruction
Adverse event was reported on Jul 15, 2009 by a Female patient taking Ontak (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 121.3 lb, Patient had the following side effects: capillary leak syndrome, cytokine release syndrome, dehydration, enteritis, muscular weakness, small intestinal obstruction. During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

6273020-2 | Abasia, Abdominal Pain, Blood Albumin Decreased, Capillary Leak Syndrome, Chills, Constipation, Cytokine Release Syndrome, Dehydration, Flushing
on Jul 16, 2009 Female patient from UNITED STATES , weighting 121.7 lb, was treated with Ontak (View Usage). After Ontak was administered, patient had the following side effects: abasia, abdominal pain (What is abdominal pain?), blood albumin decreased, capillary leak syndrome, chills, constipation (What is constipation?), cytokine release syndrome, dehydration, flushing. Ontak dosage: 4970 Mg. During the same period patient was treated with RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) (589 Mg) (View Rituximab (moab C2b8 Anti Cd20, Chimeric) Review and Rituximab (moab C2b8 Anti Cd20, Chimeric) Label ). Patient was hospitalized.

6270728-X | Cerebrovascular Accident, Embolic Stroke, Pneumonia, Respiratory Failure, Sepsis
on Jul 07, 2009 Female patient from UNITED STATES , weighting 163.1 lb, was diagnosed with lymphoma (What is lymphoma?), hypertension, pain (What is pain?) and was treated with Ontak (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident, embolic stroke, pneumonia (What is pneumonia?), respiratory failure, sepsis (What is sepsis?). Ontak dosage: . During the same period patient was treated with PREDNISONE DEXAMETHOSONE (View Prednisone-dexamethosone Review and Prednisone-dexamethosone Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), HYDROCODONE (5-500mg) (View Hydrocodone Review and Hydrocodone Label ), HYDROMORPHONE HCL (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ). Patient was hospitalized.

6264117-1 | Acute Graft Versus Host Disease, Sepsis
Patient was taking Ontak (View Usage). Patient had the following side effects: acute graft versus host disease, sepsis (What is sepsis?) on Jul 02, 2009 from UNITED STATES Additional patient health information: Male patient , 53 years of age, . Ontak dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6242577-X | Polyneuropathy
Adverse event was reported on Jun 15, 2009 by a Female patient taking Ontak (View Usage) (Dosage: ) was diagnosed with t-cell lymphoma and. Location: UNITED STATES , 59 years of age, After Ontak was administered, patient had the following side effects: polyneuropathy. Patient was hospitalized.

6221948-1 | Blood Albumin Decreased, Capillary Leak Syndrome, Cytokine Release Syndrome, Hypertension, Hypotension, Infusion Related Reaction, Nausea, Oxygen Saturation Decreased, Rash
on Jun 09, 2009 Female patient from UNITED STATES , weighting 121.7 lb, was treated with Ontak (View Usage). Patient experienced the following unwanted or unexpected effects: blood albumin decreased, capillary leak syndrome, cytokine release syndrome, hypertension, hypotension, infusion related reaction, nausea (What is nausea?), oxygen saturation decreased, rash (What is rash?). Ontak dosage: 4970 Mg. During the same period patient was treated with RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) (589 Mg) (View Rituximab (moab C2b8 Anti Cd20, Chimeric) Review and Rituximab (moab C2b8 Anti Cd20, Chimeric) Label ). Patient was hospitalized.

6213202-9 | Deep Vein Thrombosis, Hypotension
on Jun 02, 2009 Male patient from UNITED STATES , 58 years of age, weighting 114.0 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Ontak (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), hypotension. Ontak dosage: 943 Mcg Once Iv Drip. Patient was hospitalized.

6182804-0 | Application Site Oedema, Infection, Lymphadenopathy, Pain
Patient was taking Ontak (View Usage). After Ontak was administered, patient had the following side effects: application site oedema, infection (What is infection?), lymphadenopathy, pain (What is pain?) on Apr 29, 2009 from GERMANY Additional patient health information: Male patient , 15 years of age, weighting 107.6 lb, was diagnosed with mycosis fungoides stage iii, infection (What is infection?), pain (What is pain?) and. Ontak dosage: . During the same period patient was treated with REKAWAN (View Rekawan Review and Rekawan Label ), LASIX (View Lasix Review and Lasix Label ), AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ), COTRIM (View Cotrim Review and Cotrim Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), ACTIQ (View Actiq Review and Actiq Label ), HYDROMORPHONE HCL (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ). Patient was hospitalized.

6163699-8 | Visual Acuity Reduced
Adverse event was reported on Apr 20, 2009 by a Female patient taking Ontak (View Usage) (Dosage: Iv Drip) was diagnosed with angioimmunoblastic t-cell lymphoma and. Location: UNITED STATES , 64 years of age, weighting 110.0 lb, Patient experienced the following unwanted or unexpected effects: visual acuity reduced.

6154439-7 | Blood Creatine Phosphokinase Increased, Myocardial Ischaemia, Tumour Lysis Syndrome
on Apr 09, 2009 Female patient from UNITED STATES , weighting 134.5 lb, was diagnosed with t-cell lymphoma, hypercholesterolaemia, hypertension and was treated with Ontak (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, myocardial ischaemia, tumour lysis syndrome. Ontak dosage: . During the same period patient was treated with VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), DOXORUBICIN (View Doxorubicin Review and Doxorubicin Label ), CYTOXAN (View Cytoxan Review and Cytoxan Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), LIPITOR (View Lipitor Review and Lipitor Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), NEULASTA (View Neulasta Review and Neulasta Label ).

6121261-7 | Blood Creatine Phosphokinase Abnormal, Fatigue, Myalgia, Myositis
on Mar 03, 2009 Female patient from UNITED STATES , 28 years of age, weighting 299.8 lb, was diagnosed with lymphoma (What is lymphoma?) and was treated with Ontak (View Usage). After Ontak was administered, patient had the following side effects: blood creatine phosphokinase abnormal, fatigue, myalgia, myositis (What is myositis?). Ontak dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

6102889-7 | Fluid Retention, Muscle Enzyme Increased, Myalgia, Swelling
Patient was taking Ontak (View Usage). Patient experienced the following unwanted or unexpected effects: fluid retention, muscle enzyme increased, myalgia, swelling on Mar 03, 2009 from UNITED STATES Additional patient health information: Female patient , 27 years of age, weighting 250.0 lb, was diagnosed with lymphoma (What is lymphoma?) and. Ontak dosage: . Patient was hospitalized and became disabled.

6070146-3 | Febrile Neutropenia
Adverse event was reported on Jan 29, 2009 by a Female patient taking Ontak (View Usage) (Dosage: ) was diagnosed with skin lesion, hypothyroidism, prophylaxis and. Location: UNITED STATES , weighting 121.3 lb, Patient had the following side effects: febrile neutropenia. During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ).

6068468-5 | Application Site Oedema, Infection, Lymphadenopathy, Pain
on Jan 22, 2009 Male patient from GERMANY , 15 years of age, weighting 107.6 lb, was diagnosed with mycosis fungoides stage iii, renal tubular disorder, infection (What is infection?), pain (What is pain?) and was treated with Ontak (View Usage). After Ontak was administered, patient had the following side effects: application site oedema, infection (What is infection?), lymphadenopathy, pain (What is pain?). Ontak dosage: . During the same period patient was treated with REKAWAN (View Rekawan Review and Rekawan Label ), LASIX (View Lasix Review and Lasix Label ), AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ), COTRIM (View Cotrim Review and Cotrim Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), ACTIQ (View Actiq Review and Actiq Label ), HYDROMORPHONE HCL (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ). Patient was hospitalized.

6066391-3 | Leukopenia, Lymphopenia, Neutropenia, Thrombocytopenia
on Jan 29, 2009 Male patient from UNITED STATES , weighting 143.3 lb, was diagnosed with t-cell lymphoma and was treated with Ontak (View Usage). Patient experienced the following unwanted or unexpected effects: leukopenia, lymphopenia, neutropenia, thrombocytopenia. Ontak dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), NEULASTA (View Neulasta Review and Neulasta Label ), PLAVIX (View Plavix Review and Plavix Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6045648-6 | Infection
Patient was taking Ontak (View Usage). Patient had the following side effects: infection (What is infection?) on Jan 16, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 134.5 lb, . Ontak dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), NEULASTA (View Neulasta Review and Neulasta Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ), VALACYCLOVIR HYDROCHLORIDE (View Valacyclovir Hydrochloride Review and Valacyclovir Hydrochloride Label ). Patient was hospitalized.